1200 Pharma has filed a notice of an exempt offering of securities to raise $2,325,500.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, 1200 Pharma is raising up to $2,325,500.00 in new funding. Sources indicate that as part of senior management Director, Mark Attanasio played a key role…